Pfizer PFE has sold off its remaining stake in consumer health company Haleon HLN to institutional investors and Haleon ...
We suggest that investors who own GSK's stock remain invested for now, considering its sales and profits are expected to continue improving in the coming years.
NEW YORK, NY / ACCESS Newswire / March 19, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...
British investment firm SV Health Investors has secured $250 million to go toward the development of first-in-class ...
Donna Kelce, mother of NFL stars Travis and Jason Kelce, highlights the painful condition of shingles, urging those over 50 ...
The White House is reportedly considering former U.S. Rep. Michael Burgess (R-Texas) as its nominee to head the CDC. Burgess, ...
The recombinant zoster vaccine is effective in preventing herpes zoster in adults aged 50 years or older with rheumatoid ...
Andre Lacroix, who has run the testing and inspection specialist since 2015, will be the latest FTSE 100 chief to see his ...
The pharmaceutical industry on Thursday blasted the UK government's levy that aims to curb the national health system's drugs ...
Pharmaceutical Technology on MSN10h
Pfizer sells 7.3% stake in Haleon for $3.3bn
The disposal represents Pfizer's exit from its investment in Haleon, which originated from a JV formed with GSK in 2019.
Sleep Aids Market Share 2025 Sleep Aids Market is estimated to be valued at USD 83.75 Bn in 2025 and is expected to reach USD 141.77 Bn by ...
Bengaluru: Syngene International Limited has announced the conclusion of the acquisition of its first biologics site in the ...